News Sentiment

MNKD sentiment intelligence

MannKind Corp news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.

Chart Weekly report Factors RSS feed
Weighted score 57 Balanced news tone 71 relevant articles
Exchange NASDAQ United States
Sector Healthcare Market context
Industry Biotechnology Read-through group
Latest close 4.09 Week of 10 Jul 2026
Weighted tone 57/100

Balanced news tone

Market reaction Price moving ahead of tone

Price is moving more forcefully than the current news tone suggests.

Primary event Market update

79/100 classification confidence.

Company focus 63

directly relevant articles

Source quality 2

high-authority source matches

Trend context Trend inactive

-9.5% over one week, +11.7% over four weeks, trend inactive, and near fair-value range.

Latest direct headline Neutral

MannKind Corporation (MNKD) Up 20% Since Afrezza FDA Approval

Market Reaction

Price moving ahead of tone

66/100 confidence

Price is moving more forcefully than the current news tone suggests.

Primary event Market update 79/100 classification
One-week reaction -9.5% Price reacting lower
Trend fit Trend inactive 11.7% over four weeks
Fair value -13.8% Near fair-value range

Sentiment Mix

Positive, neutral, negative

Weighted by relevance
Positive 26
Neutral 36
Negative 9

Relevance

Why the article matched

Direct first
Direct company coverage 63
Industry context 8
Sector context 0

Sources

Coverage mix

Publishers
Market source 16
Insider Monkey 5
TradingView 5
TradingKey 5
Stock Titan 5
simplywall.st 4
GlobeNewswire 3
Ad Hoc News 3

Event Lens

What the news is about

Classified themes
Market update 37
Earnings 17
Regulatory and legal 10
Deals and strategy 4
Analyst action 1
Macro sensitivity 1
Guidance 1

Sentiment Trail

Score over time

50 baseline
Above 50 Neutral zone Below 50

News Tape

Relevant headlines

Showing 31-60 of 71
Insider Monkey Direct company coverage

Jim Cramer Highlighted 16 Stocks Including Quantinuum, and the Market’s Appetite for New Supply

Jim Cramer highlighted 16 stocks, including Quantinuum, indicating the market's strong appetite for new supply. Among the mentioned stocks is MannKind Corporation (NASDAQ:MNKD), which Cramer described as a "total speculation" for investors looking to balance their portfolios with

Tone
Neutral 50/100
Event
Macro sensitivity
Published
06 Jun 2026 12:49
Source
Insider Monkey
Stock Titan Direct company coverage

Inhaled insulin data explore options for kids, pregnancy and pump users

MannKind (Nasdaq: MNKD) announced new data for its inhaled insulin, Afrezza, and FUROSCIX, presented at the ADA 2026 Scientific Sessions. The findings highlight Afrezza's benefits for pediatric patients, gestational diabetes, and compatibility with automated insulin delivery syst

Tone
Positive 66/100
Event
Market update
Published
05 Jun 2026 23:10
Source
Stock Titan
AD HOC NEWS Direct company coverage

MannKind Corp stock (US5638651064): focus on valuation metrics after recent FDA and partnership news

MannKind Corp shares continue to trade in the lower single digits on Nasdaq, with recent FDA and partnership developments bringing valuation ratios into focus. The company has moved into profitability in the last twelve months, supported by inhaled therapies and collaborations, y

Tone
Positive 71/100
Event
Deals and strategy
Published
05 Jun 2026 22:26
Source
AD HOC NEWS